Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2012
02/14/2012US8114979 Di-alpha amino anthraquinone compositions
02/14/2012US8114978 Methods for genotyping selected polymorphism
02/14/2012US8114977 Proteins derived from white spot syndrome virus and uses thereof
02/14/2012US8114976 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications
02/14/2012US8114975 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway.
02/14/2012US8114973 Nucleotide analogs
02/14/2012US8114972 Tumor and infectious disease therapeutic compositions
02/14/2012US8114971 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine
02/14/2012US8114853 Methods of treating smooth muscle cell disorders
02/14/2012US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
02/14/2012US8114850 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
02/14/2012US8114848 Immunomodulatory oligonucleotides
02/14/2012US8114656 Thermostable neutral metalloproteases
02/14/2012US8114655 EGVII endoglucanase and nucleic acids encoding the same
02/14/2012US8114654 Site-specific incorporation of redox active amino acids into proteins
02/14/2012US8114650 Nucleic acid and its use effecting ciliate tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency
02/14/2012US8114641 Made from biosynthesis; can be further converted to bis(2-methyl)butyl ether or 3,3,5-trimethylheptane; fuel addtive, biofuel-fossil fuel blends, or biofuels
02/14/2012US8114640 Macrocyclization of compounds from solid support using thioesterases
02/14/2012US8114638 Arabinitol dehydrogenase from Neurospora crassa
02/14/2012US8114636 Labeling and detection of nucleic acids
02/14/2012US8114631 Nucleic acids encoding spider glue proteins and methods of use thereof
02/14/2012US8114630 Modified interferon beta polypeptides and their uses
02/14/2012US8114628 Expanding the eukaryotic genetic code
02/14/2012US8114601 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
02/14/2012US8114599 Compositions and methods for free-solution conjugate nucleic acid analysis
02/14/2012US8114598 High-sensitivity assays for pathogen detection using metal enhanced fluorescence
02/14/2012US8114596 Producing, cataloging and classifying sequence tags
02/14/2012US8114595 Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
02/14/2012US8114592 Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof
02/14/2012US8114590 Diagnosis and treatment of chronic lymphocytic leukemia (CLL)
02/14/2012US8114589 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
02/14/2012US8114587 Methods for the detection of colorectal cancer
02/14/2012US8114581 Methods and compositions for detecting neoplastic cells
02/14/2012US8114443 Phytase-expressing transgenic plants
02/14/2012US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV
02/14/2012US8114417 Recombinant protective protein from Streptococcus pneumoniae
02/14/2012US8114416 Modified oncolytic viruses
02/14/2012US8114381 Radiolabeled compounds and compositions, their precursors and methods for their production
02/14/2012CA2387870C Stabilized proteins
02/14/2012CA2128528C Process for typing of hcv isolates
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012017105A1 Microrna that can be used for treating arrhythmogenic channelopathies
02/09/2012WO2011159758A3 Long lasting drug formulations
02/09/2012WO2011150408A3 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
02/09/2012WO2011079197A3 Regulatory polynucleotides and uses thereof
02/09/2012US20120036599 Novel fungal enzymes
02/09/2012US20120036596 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
02/09/2012US20120036594 RNA-Mediated Induction of Gene Expression in Plants
02/09/2012US20120036590 Interferon-like protein zcyto21
02/09/2012US20120036589 Vaccine
02/09/2012US20120035354 Materials and methods for the modification of plant lignin content
02/09/2012US20120035353 Aligned nanostructured polymers
02/09/2012US20120035346 Luminescent compounds
02/09/2012US20120035248 Method for inhibiting the activity of mir-155
02/09/2012US20120035247 RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
02/09/2012US20120035246 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
02/09/2012US20120035245 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
02/09/2012US20120035242 Pharmaceutical composition for treating obesity or diabetes
02/09/2012US20120035241 Use of inhibitors of plac8 activity for the modulation of adipogenesis
02/09/2012US20120035240 Conserved hbv and hcv sequences useful for gene silencing
02/09/2012US20120035115 Chemical modifications of monomers and oligonucleotides with cycloaddition
02/09/2012US20120035065 Aptamer Regulated Nucleic Acids and Uses Thereof
02/09/2012US20120035060 Highly multiplexed genotyping using leukoreduced blood samples
02/09/2012US20120034675 Tyrosinase mutant and methods of use thereof
02/09/2012US20120034673 Isolated plant deoxyhypusine synthase and nucleotides encoding same
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034634 Modified luciola cruciata luciferase protein
02/09/2012US20120034612 Methods and Kits for miRNA Isolation and Quantitation
02/09/2012US20120034265 Influenza hemagglutinin and neuraminidase variants
02/09/2012US20120034263 Sequences diagnostic for shrimp pathogens
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034256 Hcv vaccines and methods for using the same
02/09/2012US20120034254 Antigenic cloaking and its use
02/09/2012US20120034248 Novel agonists of toll-like receptor 3 and methods of their use
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
02/09/2012US20120034214 Methods and kits for determining the prognosis of pulmonary sarcoidosis
02/09/2012US20120034211 EGFR antibodies comprising modular recognition domains
02/09/2012US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012DE102010038842A1 New aptamer that specifically binds to human tau protein or its fragment, useful e.g. in vitro for isolating, purifying and/or detecting tau protein, and to treat cerebral infarction, pick disease and/or progressive supranuclear palsy
02/09/2012CA2805265A1 Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
02/08/2012EP2415486A2 Conjugates and compositions for cellular delivery
02/08/2012EP2414526A1 Highly acidic chitosan-nucleic acid polyplex compositions
02/08/2012EP2414374A2 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
02/08/2012EP2414043A1 Bmp-alk3 antagonists and uses for promoting bone growth
02/08/2012EP1824872B1 Rnai modulation of mll-af4 and uses thereof
02/08/2012EP1235938B1 Fluorescent quenching detection reagents and methods
02/08/2012CN1921884B 重组核酸分子,表达盒和细菌,及其使用方法 Recombinant nucleic acid molecule, expression cassette, and bacteria, and methods of use
02/08/2012CN102348802A Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
02/08/2012CN102344477A Nucleotide and / or oligonucleotide and preparation method thereof
02/08/2012CN101492485B 一种提取裸子植物组织中rna的方法 A method of gymnosperms tissue extract rna
02/08/2012CN101113159B 预防与治疗肺癌细胞侵袭转移的反义寡核苷酸的结构及用途 Prevention and treatment of lung cancer cell invasion and metastasis antisense oligonucleotide structure and purpose
02/07/2012US8110726 Polynucleotides encoding cellulose synthase from pinus radiata and methods of use for regulating polysaccharides of a plant
02/07/2012US8110720 Transgenic mice expressing humanized VEGF
02/07/2012US8110675 TP expression-inhibiting compound and siRNA sequence thereof
02/07/2012US8110674 Therapeutic compositions
02/07/2012US8110673 Aggregation sensor and solutions and kits comprising the same
02/07/2012US8110672 Promoter engineering and genetic control